Neovletta 28 (Ethinylestradiol, Levonorgestrel | Lactose Monohydrate)

Ethinylestradiol, the active ingredient in Neovletta 28, is a combined oral contraceptive presented as an oral tablet for oral use. It works together with levonorgestrel, a progestogenic component that enhances contraceptive efficacy, to prevent pregnancy in women of reproductive age.

GNH USA supplies Neovletta 28 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality compliance with EU standards and provides reliable logistics for global distribution.

Neovletta 28 is a combined oral contraceptive indicated for hormonal contraception and related menstrual conditions.

- Contraception: prevention of pregnancy in women of childbearing potential. - Menstrual cycle regulation: helps achieve regular menstrual bleeding patterns. - Acne treatment: reduces androgen‑dependent skin lesions in women.

Neovletta 28 may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like. - Breast tenderness: swelling or discomfort. - Spotting or breakthrough bleeding: irregular bleeding between periods. - Weight gain: modest fluid retention. - Mood changes: irritability or mild depression.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Stroke or transient ischemic attack. - Myocardial infarction: heart attack in susceptible individuals. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Hepatic adenoma: benign liver tumor. - Hyperbilirubinemia: jaundice due to liver dysfunction.

Before prescribing Neovletta 28, clinicians should assess individual risk factors and contraindications.

- Pregnancy contraindication: the product must not be used during pregnancy. - Smoking restriction: avoid use in women over 35 who smoke. - Thromboembolic history: contraindicated in patients with prior venous or arterial clotting events. - Hypertension: caution in uncontrolled high blood pressure. - Liver disease: avoid in severe hepatic impairment. - Migraine with aura: use only after careful evaluation. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Neovletta 28 can interact with several medicines that alter hormone metabolism or increase clotting risk.

Major Interactions (Avoid): - Rifampicin, carbamazepine, phenytoin: enzyme inducers that reduce contraceptive effectiveness. - St. John’s wort: herbal inducer that may lower plasma hormone levels. - Certain antifungals (ketoconazole, itraconazole): may increase hormone concentrations and risk of side effects.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may affect bleeding patterns. - Antihypertensives (beta‑blockers, ACE inhibitors): monitor blood pressure control. - Diuretics: may increase risk of electrolyte imbalance. - Warfarin or other anticoagulants: observe for altered coagulation parameters.